Use of mutated antithrombins for treating or preventing coagulation disorders
US8741844B2 · kind B2 · utility
5Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 2008 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Dec 14, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/745
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of a mutated antithrombin having substantially no activity, in particular no anticoagulant activity, possibly in association with an anticoagulant, for the preparation of a drug intended for the prevention or treatment of pathologies linked to or associated with coagulation disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.